Restore Technologies, Inc

CytoLumina Technologies Corp Inc, located in Los Angeles, CA, specializes in innovative technological solutions aimed at enhancing various industry applications. The company is committed to delivering high-quality products and services tailored to meet diverse client needs. With a focus on excellence and customer satisfaction, CytoLumina Technologies continues to develop advanced technology offerings while maintaining a reputation for reliability and service. Their expertise extends to various agreements and contracts relevant to the technology sector, underscoring their comprehensive approach to business operations. Generated from the website

Partillion Bioscience Corporation, based in Los Angeles, CA, specializes in innovative solutions for functional single-cell biology research, offering the world’s first functional single-cell biology reagent platform. Their technology facilitates powerful single-cell assays, enabling researchers to predict potency and identify better antibodies through a simplified, cost-effective approach that requires no new equipment. With a focus on advancing antibody discovery and cell therapy, Partillion provides products such as biotinylated nanovials and custom workflows designed for diverse applications, including multicell assays and extracellular vesicles. Their award-winning technology allows for the screening of significant cell volumes while maintaining cell viability for downstream experiments, enhancing the potential for groundbreaking discoveries in the field of immunology and beyond. Generated from the website

Max Biopharma, Inc. is a biotechnology company based in Santa Monica, CA, focused on developing innovative therapeutic solutions through their unique approach to medicine. Their pipeline includes promising candidates such as Oxy133 and Oxy210, highlighting their commitment to advancing healthcare through scientific excellence. The company is supported by a team of dedicated scientific and business advisors, who contribute to its mission of harnessing oxysterol therapeutics. By emphasizing research and development, Max Biopharma aims to address significant medical needs and improve patient outcomes. Generated from the website